Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
AssigneeSynthetic Biologics, Inc.
InventorsMichael Kaleko, Sheila Connelly
Life of this patent
Estimating the term…
Abstract
This invention relates, in part, to various compositions and methods for protecting the gastrointestinal microbiome from antibiotic disruption.
Claims27
A method of protecting a subject's gastrointestinal microbiome, comprising administering an effective amount of a pharmaceutical composition comprising a broad spectrum carbapenemase to a subject in need thereof, wherein:
- the subject is undergoing treatment or has recently undergone treatment with a carbapenem antibiotic, and
- the broad spectrum carbapenemase is capable of degrading or inactivating the carbapenem in the subject's gastrointestinal tract.
(canceled)
-6. (canceled)
(canceled)
(canceled)
The method of claim [1] 10, wherein the microbiome-mediated disorder is one or more of an antibiotic-induced adverse effect, C. difficile infection (CDI), and a C. difficile-associated disease.
19-21. (canceled)
23-60. (canceled)
A method for producing an antibiotic-degrading agent in Escherichia coli (E. coli), comprising:
- (a) providing a host E. coli cell transformed with a vector comprising a sequence encoding the antibiotic-degrading agent;
- (b) culturing the E. coli cell to induce expression of the antibiotic-degrading agent;
- and
- (c) recovering the antibiotic-degrading agent from a soluble fraction prepared from the E. coli cell,
- wherein:
- the antibiotic-degrading agent is broad spectrum carbapenemase having at least 95% sequence identity with the amino acid sequences of SEQ ID NO:
- 68 or SEQ ID NO:
- 53 and
- the culturing is in the presence of an amount of zinc sufficient to substantially increase the amount of antibiotic-degrading agent protein in a soluble fraction and reduce the amount of antibiotic-degrading agent protein in inclusion bodies relative to culturing in the absence of zinc.
62-76. (canceled)
The method of claim 79, wherein the broad spectrum carbapenemase consists essentially of an amino acid sequence of SEQ ID NO:
- 68.
Dependencies are inferred from the claim text.